Lower numbers of circulating natural killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV-1) associated neurological disease

Clinical and Experimental Immunology

Volumn 158, Issue 3, 2009, Pages 294-299

  Ndhlovu, L C ^a,b   Snyder Cappione, J E ^a   Carvalho, K I ^a   Leal, F E ^a   Loo, C P ^a   Bruno, F R ^a   Jha, A R ^a   Devita, D ^b   Hasenkrug, A M ^a   Barbosa, H M R ^c   Segurado, A C ^c   Nixon, D F ^a   Murphy, E L ^b,d   Kallas, E G ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

CD4; CD8; HTLV 1 infection; Innate immunity; NK T cells

Indexed keywords

ADULT; ARTICLE; BRAZIL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; EFFECTOR CELL; FEMALE; HETEROZYGOTE; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER T CELL; NEUROLOGIC DISEASE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; T LYMPHOCYTE SUBPOPULATION; UNITED STATES;

ADULT; CARRIER STATE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DISEASE PROGRESSION; FEMALE; HTLV-I INFECTIONS; HUMANS; IMMUNITY, CELLULAR; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; NATURAL KILLER T-CELLS; PARAPARESIS, TROPICAL SPASTIC; T-LYMPHOCYTE SUBSETS; YOUNG ADULT;

EID: 70350582999     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2009.04019.x     Document Type: Article

References (27)

1. Orland JR, Engstrom J, Fridey J et al. Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes study. Neurology 2003 61 : 1588 1594.
2. Osame M, Usuku K, Izumo S et al. HTLV-I associated myelopathy, a new clinical entity. Lancet 1986 1 : 1031 1032. (Pubitemid 16102987)
3. Gessain A, Barin F, Vernant JC et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985 2 : 407 410.
4. Itoyama Y, Minato S, Kira J et al. Spontaneous proliferation of peripheral blood lymphocytes increased in patients with HTLV-I-associated myelopathy. Neurology 1988 38 : 1302 1307. (Pubitemid 18218622)
5. Bangham CR. Human T-cell leukaemia virus type I and neurological disease. Curr Opin Neurobiol 1993 3 : 773 778.
6. Sakai JA, Nagai M, Brennan MB, Mora CA, Jacobson S. In vitro spontaneous lymphoproliferation in patients with human T-cell lymphotropic virus type I-associated neurologic disease: predominant expansion of CD8+ T cells. Blood 2001 98 : 1506 1511.
7. Jacobson S. Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease. J. Infect Dis 2002 186 (Suppl. 2 S187 92.
8. Levin MC, Lee SM, Kalume F et al. Autoimmunity due to molecular mimicry as a cause of neurological disease. Nat Med 2002 8 : 509 513.
9. Bendelac A, Savage PB, Teyton L. The biology of NKT cells. Annu Rev Immunol 2007 25 : 297 336.
10. Snyder-Cappione JE, Nixon DF, Loo CP et al. Individuals with pulmonary tuberculosis have lower levels of circulating CD1d-restricted NKT cells. J Infect Dis 2007 195 : 1361 1364.
11. Sugawara I, Yamada H, Mizuno S, Li CY, Nakayama T, Taniguchi M. Mycobacterial infection in natural killer T cell knockout mice. Tuberculosis 2002 82 : 97 104.
12. Sada-Ovalle I, Chiba A, Gonzales A, Brenner MB, Behar SM. Innate invariant NKT cells recognize Mycobacterium tuberculosis-infected macrophages, produce interferon-gamma, and kill intracellular bacteria. PLoS Pathol 2008 4 : e1000239.
13. Li D, Xu XN. NKT cells in HIV-1 infection. Cell Res 2008 18 : 817 822.
14. van der Vliet HJ, von Blomberg BM, Hazenberg MD et al. Selective decrease in circulating V alpha 24+V beta 11+ NKT cells during HIV type 1 infection. J Immunol 2002 168 : 1490 1495.
15. Sandberg JK, Fast NM, Palacios EH et al. Selective loss of innate CD4(+) V alpha 24 natural killer T cells in human immunodeficiency virus infection. J Virol 2002 76 : 7528 7534.
16. Unutmaz D. NKT cells and HIV infection. Microb Infect 2003 5 : 1041 1047.
17. Moll M, Kuylenstierna C, Gonzalez VD et al. Severe functional impairment and elevated PD-1 expression in CD1d-restricted NKT cells retained during chronic HIV-1 infection. Eur J Immunol 2009 39 : 902 911.
18. Snyder-Cappione JE, Loo CP, Carvalho KI et al. Lower cytokine secretion ex vivo by natural killer T cells in HIV-infected individuals is associated with higher CD161 expression. AIDS 2009 15 : 1965 1970.
19. Lee PT, Benlagha K, Teyton L, Bendelac A. Distinct functional lineages of human V(alpha)24 natural killer T cells. J Exp Med 2002 195 : 637 641.
20. Gumperz JE, Miyake S, Yamamura T, Brenner MB. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J Exp Med 2002 195 : 625 636.
21. Im JS, Kang TJ, Lee SB et al. Alteration of the relative levels of iNKT cell subsets is associated with chronic mycobacterial infections. Clin Immunol 127 : 214 224.
22. Sandberg JK, Bhardwaj N, Nixon DF. Dominant effector memory characteristics, capacity for dynamic adaptive expansion, and sex bias in the innate Valpha24 NKT cell compartment. Eur J Immunol 2003 33 : 588 596.
23. Brigl M, van den Elzen P, Chen X et al. Conserved and heterogeneous lipid antigen specificities of CD1d-restricted NKT cell receptors. J Immunol 2006 176 : 3625 3634.
24. Exley MA, Hou R, Shaulov A et al. Selective activation, expansion, and monitoring of human iNKT cells with a monoclonal antibody specific for the TCR alpha-chain CDR3 loop. Eur J Immunol 2008 38 : 1756 1766.
25. Lucas M, Gadola S, Meier U et al. Frequency and phenotype of circulating Valpha24/Vbeta11 double-positive natural killer T cells during hepatitis C virus infection. J Virol 2003 77 : 2251 2257.
26. Kita H, Naidenko OV, Kronenberg M et al. Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer. Gastroenterology 2002 123 : 1031 1043.
27. Bricard G, Cesson V, Devevre E et al. Enrichment of human CD4+ V(alpha)24/Vbeta11 invariant NKT cells in intrahepatic malignant tumors. J Immunol 2009 182 : 5140 5151.